StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FLUIDOM.BO$832.60+11.08%
Fair $832.60+0.0%

FLUIDOM.BO

Fluidomat Limited

Industrials / Tools & AccessoriesBSE

$832.60

+83.05 (+11.08%)

Fairly Valued+0.0%Fair Value $832.60Fund rank 32/100 · Data gapFallback financials|
SA 40/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $78.6M · quality 62.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 78/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · FLUIDOM.BOLocal privado en este navegador · Fluidomat Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.1B

P/E

25.8x

↑

EV/EBITDA

13.3x

↑

ROE

27.6%

↑

Gross Margin

68.8%

↑

Debt/Equity

N/A

•
52-Week Range$833
$550$1419

TradingView lightweight chart

FLUIDOM.BO price, volumen y niveles de valoración

Último $832.60Periodo +33204.0%
Fair value: $832.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+28.6%

FCF CAGR

+24.4%

FCF margin

10.9%

FCF / Net income

0.35x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $721.8M · net income $222.2M · FCF $78.6M

2022-FY → 2025-FY

Gross margin

68.8%+12.4% pts

Operating margin

36.5%+19.7% pts

Net margin

30.8%+14.7% pts

FCF margin

10.9%-1.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$721.8M$721.8M$553.9M$461.2M$339.7M
Net Income$222.2M$222.2M$130.5M$96.2M$54.8M
EBITDA$307.4M$307.4M$183.2M$136.1M$80.9M
EPS45.1045.1026.5019.5311.65
Gross Margin68.8%68.8%62.4%57.7%56.3%
Operating Margin36.5%36.5%26.3%25.7%16.8%
Net Margin30.8%30.8%23.6%20.9%16.1%
Cash Flow
Free Cash Flow$78.6M$78.6M$86.1M$47.9M$40.8M
Returns
ROE27.6%27.6%21.4%19.5%13.3%
Valuation
P/E25.8325.8322.4410.9814.89
EV/EBITDA13.3313.3314.957.6110.35
P/B5.105.104.512.152.07
Growth & Yield
Revenue Growth30.3%30.3%20.1%35.7%—
EPS Growth70.2%70.2%35.7%67.6%—
Dividend Yield1.0%1.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

17.9%

exigente

EPS terminal req.

$73.88

Spread vs growth

52.3%

5Y implied EPS CAGR

14.7%

razonable

EPS terminal req.

$89.39

Spread vs growth

55.5%

10Y implied EPS CAGR

12.3%

razonable

EPS terminal req.

$143.97

Spread vs growth

57.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -1.9%

Total return

-1.9%

Start / end P/E

32.4x → 18.5x

EPS bridge

26.50 → 45.10

Residual

-30.1%

EPS growth+70.2%
Multiple rerating-42.9%
Dividend+1.0%
Residual / FX / buybacks / cross-term-30.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.